{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:30:13Z","timestamp":1790562613399,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clnu.2024.05.028","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:42:45Z","timestamp":1716824565000},"page":"1798-1811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: A systematic review"],"prefix":"10.1016","volume":"43","author":[{"given":"I.M.A.A.","family":"Van Roessel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Van Den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.","family":"Ruitenburg-van Essen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.E.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"van Santen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.05.028_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-141753","article-title":"Hormonal regulators of appetite","volume":"2009","author":"Austin","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ecl.2008.08.005","article-title":"Brain regulation of appetite and satiety","volume":"37","author":"Ahima","year":"2008","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.6065\/apem.2013.18.4.161","article-title":"Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents","volume":"18","author":"Kim","year":"2013","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.028_bib4","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity","volume":"88","author":"Harz","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/er.2018-00017","article-title":"Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review","volume":"40","author":"van Iersel","year":"2019","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.028_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11060-022-04116-2","article-title":"Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up","volume":"159","author":"Partin","year":"2022","journal-title":"J\u00a0Neuro Oncol"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.028_bib7","first-page":"503","article-title":"Hypothalamic obesity in children: pathophysiology to clinical management","volume":"28","author":"Haliloglu","year":"2015","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.028_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa247","article-title":"ROHHAD(NET) syndrome: systematic review of the clinical timeline and recommendations for diagnosis and prognosis","volume":"105","author":"Harvengt","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.clnu.2024.05.028_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad009","article-title":"Diagnostic criteria for the hypothalamic syndrome in childhood","volume":"188","author":"van Santen","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","article-title":"Hypothalamic syndrome","volume":"8","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.clnu.2024.05.028_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000515318","article-title":"Hypothalamic-Pituitary outcome after treatment for childhood craniopharyngioma","volume":"54","author":"van Schaik","year":"2021","journal-title":"Front Horm Res"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.028_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030747","article-title":"A\u00a040-year cohort study of evolving hypothalamic dysfunction in infants and young children (<3 years) with optic pathway gliomas","volume":"14","author":"Picariello","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.clnu.2024.05.028_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846124","article-title":"Transition from diencephalic syndrome to hypothalamic obesity in children with suprasellar low grade glioma: a case series","volume":"13","author":"van Roessel","year":"2022","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.028_bib14","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader-Willi syndrome","volume":"155a","author":"Miller","year":"2011","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib15","first-page":"248","article-title":"Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study","volume":"44","author":"Butler","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"21","key":"10.1016\/j.clnu.2024.05.028_bib16","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.2169\/internalmedicine.7073-21","article-title":"Subtle cardiovascular abnormalities in prader-willi syndrome might begin in young adulthood","volume":"60","author":"Kobayashi","year":"2021","journal-title":"Intern Med"},{"issue":"978","key":"10.1016\/j.clnu.2024.05.028_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/pgmj.2006.052241","article-title":"Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease","volume":"83","author":"Deepak","year":"2007","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clnu.2024.05.028_bib18","first-page":"31","volume":"vol. 14","author":"Van Schaik","year":"2021"},{"key":"10.1016\/j.clnu.2024.05.028_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846880","article-title":"Treatment of acquired hypothalamic obesity: now and the future","volume":"13","author":"Dimitri","year":"2022","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.028_bib20","first-page":"e4734","article-title":"Bariatric surgery for hypothalamic obesity in craniopharyngioma patients: a retrospective, matched case-control study","volume":"106","author":"van Santen","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.028_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41574-023-00855-y","article-title":"Targeting the central melanocortin system for the treatment of metabolic disorders","volume":"19","author":"Sweeney","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnu.2024.05.028_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2014 a web and mobile app for systematic reviews","volume":"5","author":"Mourad Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib23","first-page":"89","volume":"10","author":"Page","year":"2021","journal-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews"},{"key":"10.1016\/j.clnu.2024.05.028_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2024.05.028_bib25","series-title":"Handbook for guideline development; collaboration between international guideline harmonization group","author":"Mulder","year":"2019"},{"key":"10.1016\/j.clnu.2024.05.028_bib26","series-title":"GRADE handbook for grading quality of evidence and strength of recommendations","year":"2013"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/jpem-2021-0600","article-title":"Weight management in youth with rapid-onset obesity with hypothalamic dysregulation, hypoventilation, autonomic dysregulation, and neural crest tumor (ROHHAD-NET): literature search and case report","volume":"35","author":"Marpuri","year":"2022","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.clnu.2024.05.028_bib28","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s40618-021-01574-9","article-title":"Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches","volume":"44","author":"Muscogiuri","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1687-9856-2013-14","article-title":"Endocrine manifestations and management of Prader-Willi syndrome","volume":"2013","author":"Emerick","year":"2013","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"10.1016\/j.clnu.2024.05.028_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573396312666151123115250","article-title":"Prader-willi syndrome: clinical genetics and diagnostic aspects with treatment approaches","volume":"12","author":"Butler","year":"2016","journal-title":"Curr Pediatr Rev"},{"issue":"2","key":"10.1016\/j.clnu.2024.05.028_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000496564","article-title":"Hypothalamic obesity: prologue and promise","volume":"91","author":"Abuzzahab","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"10","key":"10.1016\/j.clnu.2024.05.028_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41574-022-00716-0","article-title":"The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits","volume":"18","author":"Hinney","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnu.2024.05.028_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/AHMT.S214893","article-title":"Dietary management for adolescents with prader-willi syndrome","volume":"11","author":"Miller","year":"2020","journal-title":"Adolesc Health Med Therapeut"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-277X.2012.01275.x","article-title":"A\u00a0reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome","volume":"26","author":"Miller","year":"2013","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13023-020-01412-w","article-title":"The modified Atkins diet in children with Prader-Willi syndrome","volume":"15","author":"Felix","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clnu.2024.05.028_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eatbeh.2016.03.008","article-title":"Nutritional intervention with hypocaloric diet for weight control in children and adolescents with Prader-Willi Syndrome","volume":"21","author":"Lima","year":"2016","journal-title":"Eat Behav"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/cen.13933","article-title":"Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome","volume":"90","author":"Irizarry","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/000992289203100409","article-title":"Successful weight loss with protein-sparing modified fast in a morbidly obese boy with panhypopituitarism, diabetes insipidus, and defective thirst regulation","volume":"31","author":"Lee","year":"1992","journal-title":"Clin Pediatr (Phila)."},{"issue":"2","key":"10.1016\/j.clnu.2024.05.028_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/oby.2008.422","article-title":"Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene","volume":"17","author":"Reinehr","year":"2009","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.028_bib40","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1210\/jc.2007-0352","article-title":"Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis","volume":"92","author":"Hainerov\u00e1","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41366-020-00673-6","article-title":"Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations","volume":"45","author":"Trier","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnu.2024.05.028_bib42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1100\/tsw.2009.105","article-title":"A\u00a0special, strict, fat-reduced, and carbohydrate-modified diet leads to marked weight reduction even in overweight adolescents with Prader-Willi syndrome (PWS)","volume":"9","author":"Bonfig","year":"2009","journal-title":"Sci World J"},{"issue":"10","key":"10.1016\/j.clnu.2024.05.028_bib43","first-page":"1063","article-title":"Food and children with Prader-Willi syndrome","volume":"130","author":"Holm","year":"1976","journal-title":"Am J Dis Child"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.028_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/nu11050960","article-title":"Melanocortin-4 receptor and Lipocalin 2 gene Variants in Spanish children with abdominal obesity: effects on BMI-SDS after a lifestyle intervention","volume":"11","author":"Morell-Azanza","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.028_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-21-0972","article-title":"Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity","volume":"186","author":"Huynh","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clnu.2024.05.028_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101206","article-title":"The melanocortin pathway and energy homeostasis: from discovery to obesity therapy","volume":"48","author":"Yeo","year":"2021","journal-title":"Mol Metabol"},{"issue":"4","key":"10.1016\/j.clnu.2024.05.028_bib47","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpeds.2003.12.031","article-title":"Predictors of attrition from a pediatric weight management program","volume":"144","author":"Zeller","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.clnu.2024.05.028_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1155\/1988\/291847","article-title":"Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrome","volume":"1","author":"Flynn","year":"1988","journal-title":"Behav Neurol"},{"key":"10.1016\/j.clnu.2024.05.028_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.comppsych.2014.12.005","article-title":"A\u00a0disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome","volume":"58","author":"Avrahamy","year":"2015","journal-title":"Compr Psychiatr"},{"key":"10.1016\/j.clnu.2024.05.028_bib50","series-title":"Hypothalamic-pituitary injury after childhood cancer and central nervous system tumors","author":"van Iersel","year":"2019"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.028_bib51","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/JPEM.2008.21.7.651","article-title":"Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up","volume":"21","author":"Schmidt","year":"2008","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.clnu.2024.05.028_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/genes10110898","article-title":"Early diagnosis in prader-willi syndrome reduces obesity and associated Co-morbidities","volume":"10","author":"Kimonis","year":"2019","journal-title":"Genes"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.028_bib53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-18-0505","article-title":"Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo)","volume":"179","author":"Boekhoff","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.028_bib54","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/oby.2009.491","article-title":"Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity","volume":"18","author":"Rakhshani","year":"2010","journal-title":"Obesity"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.028_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/children8070531","article-title":"Multidisciplinary approach for hypothalamic obesity in children and adolescents: a preliminary study","volume":"8","author":"Tessaris","year":"2021","journal-title":"Children"},{"issue":"1\u20132","key":"10.1016\/j.clnu.2024.05.028_bib56","first-page":"59","article-title":"Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment","volume":"28","author":"Meijneke","year":"2015","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.clnu.2024.05.028_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.ijo.0801317","article-title":"Body composition and resting energy expenditure in humans: role of fat, fat-free mass and extracellular fluid","volume":"24","author":"Nielsen","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"8","key":"10.1016\/j.clnu.2024.05.028_bib58","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ebiom.2015.07.007","article-title":"Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children","volume":"2","author":"Zhang","year":"2015","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.clnu.2024.05.028_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061854","article-title":"The effects of a low calorie ketogenic diet on glycaemic control variables in hyperinsulinemic overweight\/obese females","volume":"12","author":"Michalczyk","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clnu.2024.05.028_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0972-2327.138471","article-title":"The ketogenic diet and other dietary treatments for refractory epilepsy in children","volume":"17","author":"Sharma","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"issue":"7","key":"10.1016\/j.clnu.2024.05.028_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071442","article-title":"Impact of the ketogenic diet on linear growth in children: a single-center retrospective analysis of 34 cases","volume":"11","author":"Ferraris","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.clnu.2024.05.028_bib62","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1210\/jc.2003-032209","article-title":"Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma","volume":"90","author":"Goldstone","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T21:00:08Z","timestamp":1721941208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424001742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0261561424001742"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.028","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}